AYLA - Eli Lilly Reports MonarchE Data And Other News: The Good Bad And Ugly Of Biopharma
- Eli Lilly reports positive data for Phase 3 monarchE trial.
- Soligenix gets boost from Filovirus vaccine antigens data.
- Ayala Pharmaceuticals posts encouraging interim data for AL101.
For further details see:
Eli Lilly Reports MonarchE Data, And Other News: The Good, Bad And Ugly Of Biopharma